Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ANRO
ANRO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ANRO News
US Stocks Close Mixed Amid Oil Surge and Economic Data
Apr 02 2026
NASDAQ.COM
Analysis of ALTO-101 Clinical Trial Failure Impact
Apr 02 2026
stocktwits
Stock Markets Pressured by Soaring Oil Prices
Apr 02 2026
NASDAQ.COM
US Stocks Plummet as Oil Prices Surge
Apr 02 2026
NASDAQ.COM
Alto Neuroscience's Schizophrenia Drug Fails Mid-Stage Study
Apr 01 2026
stocktwits
ALTO-101 Clinical Trial Results Update
Apr 01 2026
Newsfilter
Alto Neuroscience Secures $120 Million PIPE Financing for ALTO-207 Development
Mar 16 2026
seekingalpha
Alto Secures $120 Million Financing to Advance ALTO-207 Development
Mar 16 2026
Newsfilter
Alto Neuroscience Reports FY EPS Beat and Strong Cash Position
Mar 16 2026
seekingalpha
Alto Acquires ALTO-207 to Address Treatment-Resistant Depression
Mar 16 2026
Newsfilter
Alto Neuroscience to Participate in Virtual Forum
Mar 13 2026
Newsfilter
Helus Pharma's Psychedelic Drug Achieves Phase 3 Success
Feb 26 2026
PRnewswire
Helus Pharma Achieves Breakthrough in Depression Treatment
Feb 26 2026
Newsfilter
Alto Neuroscience to Participate in Upcoming Investor Conferences
Feb 23 2026
Newsfilter
Alto Completes Patient Enrollment for ALTO-101 Clinical Trial
Feb 13 2026
Newsfilter
Healthcare Stocks Surge in After-Hours Trading
Jan 28 2026
NASDAQ.COM
Show More News
